Clinical trial
Effect of Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis
NCT02954926 is registered in ClinicalTrials.gov with Hormozgan University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis
- Lead sponsor
- Hormozgan University of Medical Sciences
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2015
- Completion date
- November 30, 2016
- Enrollment
- 92 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.